PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 18, 2024Advanced Science21 citationsOpen Access

An Osteoimmunomodulatory Biopatch Potentiates Stem Cell Therapies for Bone Regeneration by Simultaneously Regulating IL‐17/Ferroptosis Signaling Pathways

View Full Paper
SLShan LiuWWWenle WangZCZhiyu Chen

Key Points

Key points are not available for this paper at this time.

Abstract

Currently, there are still great challenges in promoting bone defect healing, a common health problem affecting millions of people. Herein an osteoimmunity-regulating biopatch capable of promoting stem cell-based therapies for bone regeneration is developed. A totally biodegradable conjugate is first synthesized, which can self-assemble into bioactive nano micelles (PPT NMs). This nanotherapy effectively improves the osteogenesis of periodontal ligament stem cells (PDLSCs) under pathological conditions, by simultaneously regulating IL-17 signaling and ferroptosis pathways. Incorporation of PPT NMs into biodegradable electrospun nanofibers affords a bioactive patch, which notably improves bone formation in two rat bone defect models. A Janus bio patch is then engineered by integrating the bioactive patch with a stem cell sheet of PDLSCs. The obtained biopatch shows additionally potentiated bone regeneration capacity, by synergistically regulating osteoimmune microenvironment and facilitating stem cell differentiation. Further surface functionalization of the biopatch with tannic acid considerably increases its adhesion to the bone defect, prolongs local retention, and sustains bioactivities, thereby offering much better repair effects in rats with mandibular or cranial bone defects. Moreover, the engineered bioactive patches display good safety. Besides bone defects, this osteoimmunity-regulating biopatch strategy can be applied to promote stem cell therapies for spinal cord injury, wound healing, and skin burns.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Liu et al. (2024) studied this question.

synapsesocial.com/papers/68e5fc83b6db643587590cbfhttps://doi.org/10.1002/advs.202401882
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Dual‐Bioresponsive and Programmable Microneedle Matrix as a Bioinspired Coupler for Orchestrating Diabetic Bone Regeneration2026
  2. 2Enhanced Bone Regeneration via Dual Immune‐Modulatory Scaffold: Integrating Lipopolysaccharide/Gelatin Methacrylate and Proanthocyanidins/Polylactic Acid to Enhance Macrophage Recruitment and M2 Phenotype Polarization2025
  3. 3A Janus Microsphere Delivery System Orchestrates Immunomodulation and Osteoinduction by Fine‐tuning Release Profiles2024 · 8 citations
  4. 4Biomimetic sequential immuno-osteogenic regulation via a dual-drug delivery system with PDA coating on sulfonated PEEK promotes bone defect repair2026
  5. 53D Bioprinted Tissue‐Engineered Bone with Enhanced Mechanical Strength and Bioactivities: Accelerating Bone Defect Repair through Sequential Immunomodulatory Properties2024 · 7 citations